SCHEMBL7310255

SCHEMBL7310255

COc1ccc(SC(CC(=O)NOC(C)(C)C)CC2CCCC2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 2/20 0.43
MMP3 P08254 4/20 0.41
MMP1 P03956 4/20 0.41
MMP2 P08253 3/20 0.41
KLK7 P49862 2/20 0.40
NPC1 O15118 3/20 0.40
RAB9A P51151 3/20 0.40
PPARA Q07869 1/20 0.40
ALDH1A1 P00352 4/20 0.39
MDM2 Q00987 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
MMP9 P14780 1/20 0.39
MMP13 P45452 1/20 0.39
ADAM17 P78536 1/20 0.39
KMT2A Q03164 1/20 0.38
REN P00797 1/20 0.38
CTSK P43235 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2D6 P10635 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7308194 0.86 MMP3 (0.53) EPHX2MMP3MMP1MMP2KLK7
SCHEMBL7304794 0.83 EPHX2 (0.43) EPHX2MMP3MMP1MMP2KLK7
SCHEMBL7308312 0.78 ALDH1A1 (0.41) EPHX2MMP3MMP1KLK7NPC1
SCHEMBL7304806 0.78 PPARG (0.44) MMP3MMP1MMP2NPC1RAB9A
SCHEMBL7311450 0.77 MMP3 (0.63) EPHX2MMP3MMP1MMP2ALDH1A1
SCHEMBL7310697 0.73 SNCA (0.44) MMP3MMP1MMP2PPARAALDH1A1
SCHEMBL27461841 0.71 ALDH1A1 (0.42) EPHX2MMP3MMP1MMP2NPC1
SCHEMBL7310105 0.69 PPARG (0.42) EPHX2MMP1MMP2PPARAMMP13
SCHEMBL7311029 0.69 CTSS (0.39) MMP2ALDH1A1KMT2ACTSKCYP1A2
SCHEMBL7312224 0.68 ADAM17 (0.48) MMP3MMP1MMP2NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0780386-B1 Matrix metalloprotease inhibitors HOFFMANN LA ROCHE (CH) 2002-10-02 EP disclosed
US-5932595-A ANTIARTHRITIC AGENT; MULTIPLE SCLEROSIS; OSTEOPOROSIS; RESPIRATORY SYSTEM DISORDERS; SKIN DISORDERS; ANTIULCER AGENT SYNTEX (U.S.A.) INC. (US) 1999-08-03 US disclosed
EP-0780386-A1 Matrix metalloprotease inhibitors F. HOFFMANN-LA ROCHE AG (CH) 1997-06-25 EP disclosed